Genome-Wide RNAi Global Initiative Grows

Lafayette, Colorado-based Dharmacon, Inc., now a wholly owned subsidiary Fisher Scientific International (NYSE: FSH) continues to grow their Genome-Wide RNAi Global Initiative by recently adding new members including: Harvard Medical School,
Stanford University SOM and the VU University Medical Center, Amsterdam.

The Genome-Wide RNAi Global Initiative is an alliance of biomedical researchers, established to increase and accelerate the utility of human genome-wide siRNA libraries. These libraries have the potential to fundamentally change biological research by dramatically increasing scientists' ability to understand disease mechanisms and facilitating faster new drug discovery and development. The Global Initiative is providing a forum for member institutions to share research protocols, establish experimental standards and develop mechanisms for exchanging and comparing screening data.

Founding members include: The Campbell Family Institute for Breast Cancer Research, (Princess Margaret Hospital), Samuel Lunenfeld Research Institute (Mount Sinai Hospital), The London Research Institute, The Institute of Cancer Research, The German Cancer Research Center, University of Nebraska Medical Center Eppley Cancer Center, Netherlands Cancer Institute, The Scottish Centre for Genomic Technology, University of Texas Southwestern Medical Center, Yale University, The University of Texas M. D. Anderson Cancer Center, Cambridge Institute for Medical Research, and the
MRC Cancer Cell Unit.